SS Innovations International Inc. (NASDAQ: SSII) will bring its SSi Mantra surgical robotic system to the Society of Robotic Surgery (SRS) 2026 Annual Meeting, scheduled for July 23-26 in Hollywood, Florida. The company announced that the event will showcase the platform's expanding clinical experience and focus on remote surgical capabilities. The SSi Mantra will be demonstrated throughout the conference and featured in multiple technical sessions, including a live robotic telesurgery broadcast from India, where a partial nephrectomy will be performed remotely. This demonstration highlights the system's potential to extend surgical expertise across geographic boundaries.
As of July 6, 2026, more than 12,375 procedures have been completed using the SSi Mantra system, encompassing cardiac, pediatric, and telesurgical procedures. Approximately 2,100 physicians have been trained on the platform, which has been utilized across over 170 different surgical procedures. These milestones reflect the system's growing adoption and versatility. Dr. Sudhir Srivastava, Chairman and CEO of SS Innovations, will participate in multiple conference presentations covering telesurgery, robotic surgery adoption, and regulatory developments. The company's presence at SRS 2026 underscores its commitment to advancing robotic surgery through innovation and global collaboration.
The SRS Annual Meeting is one of the largest gatherings of robotic surgery specialists, providing a platform for SS Innovations to engage with key opinion leaders and potential partners. The live telesurgery broadcast is expected to generate significant interest, as it demonstrates the SSi Mantra's ability to perform complex procedures remotely, potentially expanding access to specialized surgical care in underserved regions. For more details on the event, visit the SRS meeting page at https://ibn.fm/FkgsY.
SS Innovations continues to build its global clinical footprint, with the SSi Mantra system already deployed in multiple countries. The company's focus on telesurgery aligns with broader trends in healthcare toward telemedicine and remote patient care. By enabling surgeons to operate from distant locations, the SSi Mantra platform could reduce barriers to specialized surgical care, particularly in rural or resource-limited settings. The company's newsroom provides additional updates at https://ibn.fm/SSII.
The SRS 2026 meeting will also feature technical sessions where Dr. Srivastava will discuss the clinical outcomes achieved with the SSi Mantra, including data from the over 12,000 procedures performed to date. These presentations will highlight the system's safety profile and efficacy across a wide range of surgical disciplines. As robotic surgery adoption accelerates globally, SS Innovations is positioning the SSi Mantra as a cost-effective and versatile alternative to established systems. The company's emphasis on training over 2,100 physicians suggests a commitment to building a skilled user base, which is critical for long-term adoption.
In summary, SS Innovations' participation in SRS 2026, coupled with the live telesurgery demonstration and extensive clinical data, reinforces the SSi Mantra's role in the evolving landscape of robotic surgery. The event serves as a platform to showcase the system's capabilities and to foster discussions on the future of telesurgery and surgical robotics.
